Pricing Log in Create free account

Immunovant, Inc. (IMVT) vs Oruka Therapeutics, Inc. (ORKA)

Immunovant, Inc. and Oruka Therapeutics, Inc. are both Biotechnology companies. Immunovant, Inc. and Oruka Therapeutics, Inc. are of similar size ($6.4B and $5.9B). Across the 9 metrics below, Oruka Therapeutics, Inc. leads on 7 and Immunovant, Inc. on 2.

Valuation

Metric IMVT ORKA Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 7.99 5.47 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (9.87%) (2.19%) (34.89%)
Free cash flow yield (7.07%) (1.66%) (24.52%)

Profitability

Metric IMVT ORKA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (80.10%) (18.30%) (50.12%)
Return on assets (71.10%) (17.76%) (45.60%)
Return on invested capital 0.00% (40.22%) 0.00%

Growth

Metric IMVT ORKA Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (1.47%) 52.20% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMVT ORKA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.27 38.51 4.89
Net debt to EBITDA 1.69 2.65 1.01

Dividend

Metric IMVT ORKA Biotechnology median
Dividend yield — 0.00% 0.41%
Payout ratio — — —

Size

Metric IMVT ORKA Biotechnology median
Market cap 5.86b 6.36b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack